SCHEMBL2898683

SCHEMBL2898683

Fc1ccccc1-c1cnco1.OBO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.47
NOTUM Q6P988 2/20 0.42
IMPDH2 P12268 2/20 0.41
HDAC4 P56524 1/20 0.41
IMPDH1 P20839 1/20 0.41
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
ADRA1A P35348 2/20 0.40
PTK2 Q05397 1/20 0.39
AAK1 Q2M2I8 1/20 0.39
ADRA1D P25100 1/20 0.37
ADRA1B P35368 1/20 0.37
ATR Q13535 1/20 0.37
GAA P10253 1/20 0.37
LMNA P02545 1/20 0.37
PKM P14618 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
MAP4K4 O95819 1/20 0.37
GABRG2 P18507 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38656167 0.93 PDK2 (0.48) PDK2NOTUMIMPDH2HDAC4IMPDH1
SCHEMBL9955245 0.93 PDK2 (0.48) PDK2NOTUMIMPDH2HDAC4IMPDH1
SCHEMBL1903692 0.74 PDK2 (0.48) PDK2NOTUMIMPDH2IMPDH1CYP11B1
SCHEMBL30177609 0.72 IMPDH2 (0.50) PDK2IMPDH2IMPDH1PTK2AAK1
SCHEMBL29541692 0.71 IMPDH2 (0.49) PDK2NOTUMIMPDH2IMPDH1CYP11B1
SCHEMBL26259988 0.71 MEN1 (0.48) PDK2NOTUMIMPDH2IMPDH1CYP11B1
SCHEMBL26259975 0.71 CYP11B1 (0.48) PDK2NOTUMIMPDH2IMPDH1CYP11B1
SCHEMBL1328549 0.71 GAA (0.50) PDK2NOTUMIMPDH2IMPDH1CYP11B1
SCHEMBL30570522 0.71 MAP4K4 (0.49) PDK2NOTUMIMPDH2HDAC4IMPDH1
SCHEMBL4457202 0.71 MAP4K4 (0.49) PDK2NOTUMIMPDH2HDAC4IMPDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286211-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS RANBAXY LABORATORIES LIMITED (IN) 2010-11-11 US disclosed
EP-1799677-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS Ranbaxy Laboratories Limited (IN) 2007-06-27 EP disclosed
WO-2006038100-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS RANBAXY LABORATORIES LIMITED (IN) 2006-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286211-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS OXA1L, PDK4, MLYCD PDK2 11/4885NOTUM 1839/4885IMPDH2 980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.